The Safety of Systemic Treatments That Can Be Used for Geriatric Psoriasis Patients: A Review

Chu, C. H. (2022). Risk of Serious Infectious Illness in People Diagnosed with Psoriasis and Received Treatment: A Systematic Review [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202201502
邵時傑、楊宗翰、陳玉瑩（2016）。New Pharmacological Treatment in Psoriatic Arthritis。醫學與健康期刊，5(2)，95-102。https://www.airitilibrary.com/Article/Detail?DocID=23046856-201609-201609190017-201609190017-95-102
Fei, P. C., Bianchi, L., Bonifati, C., Trento, E., Ruzzetti, M., Francesconi, F., Bultrini, S., D’Agosto, G., Bordignon, V., Francavilla, V., Tripiciano, A., Chiricozzi, A., Campione, E., Cavallotti, C., Orlandi, A., Berardesca, E., Carlo, A. D., Chimenti, S., & Ensoli, F. (2014). Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis. Mediators of Inflammation, (2014-2), 129-139. https://doi.org/10.1155/2014/236060
林明秀（2009）。On the Comorbidities and Medical Utilization in Psoriasis Patients〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2009.10152
陳杰（2020）。Diagnosis and Management of Psoriasis-A Narrative Review。北市醫學雜誌，()，1-11。https://doi.org/10.6200/TCMJ.202301/PP.0002